| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 12/18/2008 | CA2690124A1 C3b antibodies and methods for the prevention and treatment of complement-associated disorders |
| 12/18/2008 | CA2687896A1 Inhibitors of receptor tyrosine kinases and methods of use thereof |
| 12/18/2008 | CA2687746A1 Methods of treating, diagnosing and detecting fgf21-associated disorders |
| 12/18/2008 | CA2683287A1 Novel glycosylated peptide target in neoplastic cells |
| 12/18/2008 | CA2677835A1 Use of il-23 antagonists for treatment of infection |
| 12/18/2008 | CA2667788A1 Staphylococcus aureus specific anti-infectives |
| 12/17/2008 | EP2003213A2 Expression profile of prostate cancer |
| 12/17/2008 | EP2003203A1 Ligand for receptor activator of nf-kappa b, ligand is member of TNF superfamily |
| 12/17/2008 | EP2003202A2 G protein-coupled receptor up-regulated in prostate cancer and uses thereof |
| 12/17/2008 | EP2003201A2 Compounds and methods for therapy and diagnosis of lung cancer |
| 12/17/2008 | EP2002827A2 Methods and compositions for control of bone formation via modulation of sympathetic tone |
| 12/17/2008 | EP2002263A2 Cancer immunotherapy compositions and methods of use |
| 12/17/2008 | EP2001907A2 Methods and compositions for antagonism of rage |
| 12/17/2008 | EP2001515A2 Ige directed dna vaccination |
| 12/17/2008 | EP2001510A2 Methods of treating lupus using cd4 antibodies |
| 12/17/2008 | EP2001492A1 A method of treating cancer and/or cellular proliferative conditions and agents targeting hyaluronan anabolism useful for same |
| 12/17/2008 | EP1536778B1 Proteins binding to cross-beta structure comprising amyloid and methods for modulation of the cross-beta structure, its formation and its associated toxicity |
| 12/17/2008 | EP1472275B1 Protein purification |
| 12/17/2008 | EP1322669B1 Stabilisation of immunoglobulins at low pH by adding cereals or oatmeal soup or oat flour |
| 12/17/2008 | EP1230214B1 Novel genes tzap7/a, tzap7/b and tzap7 involved in t cell activation and uses thereof |
| 12/17/2008 | EP1144607B1 Methods for displaying (poly)peptides/proteins on bacteriophage particles via disulfide bonds |
| 12/17/2008 | EP1007696B1 Il-13 receptor specific chimeric proteins and uses thereof |
| 12/17/2008 | EP1007673B1 Novel bone mineralization proteins, dna, vectors, expression systems |
| 12/17/2008 | EP0791067B1 Protein kinase npk-110 |
| 12/17/2008 | CN101326197A Human monoclonal antibodies to O8E |
| 12/17/2008 | CN101326196A Neuropilin antagonists |
| 12/17/2008 | CN101326195A 抗il-17抗体 Anti-il-17 antibody |
| 12/17/2008 | CN101325972A A beta 1-42 specific monoclonal antibodies with therapeutic properties |
| 12/17/2008 | CN101325968A Anti-CTLA-4 antibody compositions |
| 12/17/2008 | CN101323642A Method for preparing bacillus coli 0157:H7 antigen monoclonal antibody by subtractive immunization |
| 12/17/2008 | CN101322844A Non-virus non-structural protein foot-and-mouth disease vaccine and preparation thereof |
| 12/17/2008 | CN100443502C Vitellus immune globulin for preventing prawn virus, tis preparing method and use thereof |
| 12/17/2008 | CN100443118C Dosages for treatment with anti-ErbB2 antibodies |
| 12/17/2008 | CN100443116C Compositions and methods for treating or preventing pneumococcal infection |
| 12/16/2008 | US7465790 Therapeutic antibodies |
| 12/16/2008 | US7465787 Transforming microorganism and monitoring expression of heterologous proteins on cell surface; monitoring protein-protein interactions and identifying modulators for treating autoimmune and cell proliferative diseases |
| 12/16/2008 | US7465786 Nucleotide sequences coding polypeptide for use in the treatment of tumor and cell proliferative disorders |
| 12/16/2008 | US7465785 Polypeptide encoded by a nucleic acid over-expressed in melanoma |
| 12/16/2008 | US7465705 Immunogenic Nogo receptor-1 polypeptides, Nogo receptor-1 antibodies; diabetic neuropathy; brain injury, spinal cord injury |
| 12/16/2008 | US7465572 De-immunized streptokinase |
| 12/16/2008 | US7465554 Gene encoding a multidrug-resistance human P-glycoprotein homologue on chromosome 7p15-2 and uses thereof |
| 12/16/2008 | US7465550 Method for screening taste-modulating compounds |
| 12/16/2008 | US7465547 sandwich method, are able to quantitatively or qualitatively determine human low-molecular-weight CD14 with high sensitivity and specificity in a simple manner, so that they are useful for the diagnosis of a patient suffering from sepsis |
| 12/16/2008 | US7465464 Populations of cells that express flk-2 receptors |
| 12/16/2008 | US7465451 Monoclonal antibodies against the interferon receptor, with neutralizing activity against type I interferon |
| 12/16/2008 | US7465450 Methods and compositions relating to anti-interleukin-4 receptor antibodies |
| 12/16/2008 | US7465449 Anti-αvβ6 antibodies |
| 12/16/2008 | US7465448 Chemokine receptor antagonists as therapeutic agents |
| 12/16/2008 | US7465446 Surrogate therapeutic endpoint for anti-CTLA4-based immunotherapy of disease |
| 12/16/2008 | US7465445 Methods of preventing or treating graft versus host reaction by administering an antibody or portion thereof that binds to AILIM |
| 12/16/2008 | US7465444 Methods of suppressing or treating an inflammatory bowel disease by administering an antibody or portion thereof that binds to AILIM |
| 12/16/2008 | US7465443 Acellular antibordetella vaccine |
| 12/16/2008 | CA2449071C Chimaeric phages |
| 12/16/2008 | CA2239692C Diagnosis and treatment of aur-1 and/or aur-2 related disorders |
| 12/11/2008 | WO2008151319A2 Expression of soluble antibody fragment by truncation of ch1 domain |
| 12/11/2008 | WO2008151200A2 Cancer related isoforms of components of transcription factor complexes as biomarkers and drug targets |
| 12/11/2008 | WO2008151088A2 Immunoglobulin constant region fc receptor binding agents |
| 12/11/2008 | WO2008151037A1 Peptide-based stat inhibitor |
| 12/11/2008 | WO2008150949A1 HUMANIZED ANTIBODIES TO Aß(20-42) GLOBULOMER AND USES THEREOF |
| 12/11/2008 | WO2008150946A1 HUMANIZED ANTIBODIES WHICH BIND TO Aβ (1-42) GLOBULOMER AND USES THEREOF |
| 12/11/2008 | WO2008150929A1 Topical compositions comprising a macromolecule and methods of using same |
| 12/11/2008 | WO2008150841A1 Compositions and methods for binding lysophosphatidic acid |
| 12/11/2008 | WO2008150577A1 Vaccine for the prevention of breast cancer relapse |
| 12/11/2008 | WO2008150525A1 Anti-notch1 nrr antibodies and methods using same |
| 12/11/2008 | WO2008150494A1 Methods and compositions for inhibiting cd32b expressing cells |
| 12/11/2008 | WO2008150485A2 Erbb2 binding proteins and use thereof |
| 12/11/2008 | WO2008150158A1 Novel plant virus designated tomato marchitez virus |
| 12/11/2008 | WO2008149526A1 Novel sugar-chain-modified haptoglobin |
| 12/11/2008 | WO2008149150A2 Polypeptides, antibody variable domains and antagonists |
| 12/11/2008 | WO2008149149A2 Polypeptides, antibody variable domains and antagonists |
| 12/11/2008 | WO2008149148A2 Polypeptides, antibody variable domains and antagonists |
| 12/11/2008 | WO2008149147A2 Polypeptides, antibody variable domains and antagonists |
| 12/11/2008 | WO2008149146A2 Polypeptides, antibody variable domains and antagonists |
| 12/11/2008 | WO2008149144A2 Polypeptides, antibody variable domains and antagonists |
| 12/11/2008 | WO2008149143A2 Methods for selecting protease resistant polypeptides |
| 12/11/2008 | WO2008148884A1 Compositions and methods for treating pancreatic tumors |
| 12/11/2008 | WO2008148761A1 Induction of tolerogenic phenotype in mature dendritic cells |
| 12/11/2008 | WO2008148546A2 Composition of a first non-labeled monoclonal antibody binding to a tumor antigen and a non-cross reactive second monoclonal antibody labeled with a nir fluorescence label |
| 12/11/2008 | WO2008148193A1 Fhl1 mutations associated with novel x-linked muscular myopathies |
| 12/11/2008 | WO2008148170A1 Human metapneumovirus immunogenic peptides, compositions, and methods of use |
| 12/11/2008 | WO2008148166A1 Clostridial toxin netb |
| 12/11/2008 | WO2008148149A1 Method of treatment or inhibition of enterovirus 71 infection |
| 12/11/2008 | WO2008124858A3 Targeted receptor |
| 12/11/2008 | WO2008124170A3 SELECTION OF HUMAN TNFα SPECIFIC ANTIBODIES |
| 12/11/2008 | WO2008122441A9 Anti-amyloid antibodies and their use in diagnosis and therapy of amyloid diseases |
| 12/11/2008 | WO2008120101A3 The ed-a antigen of fibrinogen is associated with the neovasculature of tumour metastases |
| 12/11/2008 | WO2008116219A3 Uses of monoclonal antibody 8h9 |
| 12/11/2008 | WO2008115580A3 Method for detecting nitrofuran |
| 12/11/2008 | WO2008112680A3 Global polyclonal antibodies, process for depleting commonly shared proteins by same, devices using same |
| 12/11/2008 | WO2008106131A3 Combination therapy for treatment of immune disorders |
| 12/11/2008 | WO2008065384A3 Antibodies specific for the complex of interleukin-6 and the interleukin-6 receptor |
| 12/11/2008 | WO2008057457A3 Antagonists of pcsk9 |
| 12/11/2008 | WO2008006102A3 Use of retro-aldol reaction to generate reactive vinyl ketone for attachment to anitibody molecules by michael addition reaction for use in immunostaining and immunotargeting |
| 12/11/2008 | WO2008005556A3 Tat-048 and methods of assessing and treating cancer |
| 12/11/2008 | WO2008002620A3 Cell model for alzheimer's disease pathology |
| 12/11/2008 | WO2007136679A3 Targeting vegf-b regulation of fatty acid transporters to modulate human diseases |
| 12/11/2008 | WO2007121354A3 Binding proteins comprising immunoglobulin hinge and fc regions having altered fc effector functions |
| 12/11/2008 | WO2007109052A3 Methods of treating lupus using cd4 antibodies |
| 12/11/2008 | WO2007103048A3 Tlr agonist (flagellin)/cd40 agonist/antigen protein and dna conjugates and use thereof for inducing synergistic enhancement in immunity |
| 12/11/2008 | WO2007025977A8 Anti-tnf alpha producing lactic acid bacteria for the treatment of chronic enterocolitis |